Abstract
We have investigated the effectiveness of chemotherapy for patients with recurrent adeno- and adenoidcystic carcinomas in the head and neck. Fourteen cases received a monthly combination chemotherapy regimen of cyclophosphamide, pirarubicin and cisplatin (CAP therapy). A response rate of 36% (5/14) was achieved. There was one complete response and four partial responses. The median duration of response was 37 months in the complete response case and 16 months (range, 6 to 20) in the partial response cases. The toxicity of this chemotherapy was acceptable. The result demonstrates that CAP therapy is an effective regimen for adeno- and adenoidcystic carcinomas. It may also be available as induction or adjuvant chemotherapy for patients with advanced tumors of these cancers.
Similar content being viewed by others
References
Belani CP, Eisenberger MA, Gray C (1988) Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Med Pediatr Oncol 16:197–202
Creagan ET, Woods JE, Schutt AJ, Ofallon JR (1983) Cyclophosphamide, Adriamycin, andcis-diamminedichloro-platinum II in the treatment of advanced nonsquamous cell head and neck cancer. Cancer 52:2007–2010
Creagan ET, Woods JE, Rubin J, Schaid DJ (1988) Cisplatin based chemotherapy for neo-plasms arising from salivary glands and contiguous structures in the head and neck. Cancer 62:2313–2319
Devita VT, Hellman S, Rosenberg SA (1985) Cancer, principles and practive of oncology, 2nd edn. Lippincott, Philadelphia
Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM, Miller D (1987) Cyclophosphmaide, doxorubicin and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 60:2869–2872
Eisenberger MA (1985) Supporting evidence for an active treatment program for advanced salivary gland carcinomas. Cancer Treat Rep 69:319–321
Fu KK, Liebel SA, Levine ML (1977) Carcinoma of the major and minor salivary glands. Cancer 40:2882–2890
Haan LD de, Mulder HM de, Vermorken JB, Schornagel JH, Vermey A, Verweij J (1992) Cisplating-based chemotherapy in advanced adenoidcystic carcinoma of the head and neck. Head Neck 14:273–277
Hesketh PJ, Gandara DR (1991) Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 83:613–620
Kaplan MJ, Johns ME, Cantrell RW (1986) Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 95:165–170
Posner MR, Erbin TJ, Weichselbaum RR, Fabian RL, Miller D (1982) Chemotherapy of advanced salivary gland neoplasms. Cancer 50:2261–2264
Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD (1987) Cisplatin, doxorubicin and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the northern California oncology group. J Clin Oncol 5:951–955
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsukuda, M., Kokatsu, T., Ito, K. et al. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck. J Cancer Res Clin Oncol 119, 756–758 (1993). https://doi.org/10.1007/BF01195348
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01195348